These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 9182550)
21. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. Dorschner RA; Pestonjamasp VK; Tamakuwala S; Ohtake T; Rudisill J; Nizet V; Agerberth B; Gudmundsson GH; Gallo RL J Invest Dermatol; 2001 Jul; 117(1):91-7. PubMed ID: 11442754 [TBL] [Abstract][Full Text] [Related]
22. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. Braff MH; Di Nardo A; Gallo RL J Invest Dermatol; 2005 Feb; 124(2):394-400. PubMed ID: 15675959 [TBL] [Abstract][Full Text] [Related]
23. The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. Chamorro CI; Weber G; Grönberg A; Pivarcsi A; Ståhle M J Invest Dermatol; 2009 Apr; 129(4):937-44. PubMed ID: 18923446 [TBL] [Abstract][Full Text] [Related]
24. Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. Kim JE; Kim BJ; Jeong MS; Seo SJ; Kim MN; Hong CK; Ro BI J Korean Med Sci; 2005 Aug; 20(4):649-54. PubMed ID: 16100459 [TBL] [Abstract][Full Text] [Related]
25. Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes. Chen X; Takai T; Xie Y; Niyonsaba F; Okumura K; Ogawa H Biochem Biophys Res Commun; 2013 Apr; 433(4):532-7. PubMed ID: 23524263 [TBL] [Abstract][Full Text] [Related]
26. Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis. Murakami M; Kaneko T; Nakatsuji T; Kameda K; Okazaki H; Dai X; Hanakawa Y; Tohyama M; Ishida-Yamamoto A; Sayama K PLoS One; 2014; 9(10):e110677. PubMed ID: 25330301 [TBL] [Abstract][Full Text] [Related]
27. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. Murakami M; Ohtake T; Dorschner RA; Schittek B; Garbe C; Gallo RL J Invest Dermatol; 2002 Nov; 119(5):1090-5. PubMed ID: 12445197 [TBL] [Abstract][Full Text] [Related]
28. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Oren Z; Lerman JC; Gudmundsson GH; Agerberth B; Shai Y Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):501-13. PubMed ID: 10417311 [TBL] [Abstract][Full Text] [Related]
29. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Frohm Nilsson M; Sandstedt B; Sørensen O; Weber G; Borregaard N; Ståhle-Bäckdahl M Infect Immun; 1999 May; 67(5):2561-6. PubMed ID: 10225921 [TBL] [Abstract][Full Text] [Related]
30. Cathelicidins: a family of endogenous antimicrobial peptides. Lehrer RI; Ganz T Curr Opin Hematol; 2002 Jan; 9(1):18-22. PubMed ID: 11753073 [TBL] [Abstract][Full Text] [Related]
31. Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice. Iacob SA; Iacob DG Protein Pept Lett; 2014; 21(12):1247-56. PubMed ID: 25101632 [TBL] [Abstract][Full Text] [Related]
32. Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Mallbris L; Carlén L; Wei T; Heilborn J; Nilsson MF; Granath F; Ståhle M Exp Dermatol; 2010 May; 19(5):442-9. PubMed ID: 19645825 [TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. Wang Y; Agerberth B; Löthgren A; Almstedt A; Johansson J J Biol Chem; 1998 Dec; 273(50):33115-8. PubMed ID: 9837875 [TBL] [Abstract][Full Text] [Related]
35. The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. Conner K; Nern K; Rudisill J; O'Grady T; Gallo RL J Am Acad Dermatol; 2002 Sep; 47(3):347-50. PubMed ID: 12196742 [TBL] [Abstract][Full Text] [Related]
36. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Gudmundsson GH; Agerberth B; Odeberg J; Bergman T; Olsson B; Salcedo R Eur J Biochem; 1996 Jun; 238(2):325-32. PubMed ID: 8681941 [TBL] [Abstract][Full Text] [Related]
37. Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. Bucki R; Namiot DB; Namiot Z; Savage PB; Janmey PA J Antimicrob Chemother; 2008 Aug; 62(2):329-35. PubMed ID: 18456648 [TBL] [Abstract][Full Text] [Related]
38. Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. Pazgier M; Ericksen B; Ling M; Toth E; Shi J; Li X; Galliher-Beckley A; Lan L; Zou G; Zhan C; Yuan W; Pozharski E; Lu W Biochemistry; 2013 Mar; 52(9):1547-58. PubMed ID: 23406372 [TBL] [Abstract][Full Text] [Related]
39. The role of cathelicidins in the innate host defenses of mammals. Zanetti M Curr Issues Mol Biol; 2005 Jul; 7(2):179-96. PubMed ID: 16053249 [TBL] [Abstract][Full Text] [Related]
40. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. Nagaoka I; Tamura H; Hirata M J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]